Impacto de la Adopción y Entrenamiento de Perros en Veteranos con Síntomas de Estrés Postraumático y/o Otras Condiciones de Salud Mental (VCRM)
Evaluación de Indicadores Biopsicosociales Vinculados a la Respuesta al Tratamiento con Intervención Canina en Veteranos con Síntomas de Estrés Postraumático y/o Otras Condiciones de Salud Mental
The goal of this single-arm study is to learn if a dog adoption and training program can treat, prevent in [describe participant population/primary condition; could include any of the following: sex/gender, age groups, healthy volunteers]. The main questions it aims to answer are:
- Does the dog adoption and training program decrease posttraumatic stress symptoms in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease stress and improve psychosocial health in veterans with self-reported posttraumatic stress symptoms?
- Does the dog adoption and training program decrease inflammation, increase oxytocin, and change the structure and resting-state function of specific brain regions in veterans with self-reported posttraumatic stress symptoms?
Participants will:
- Attend eight one-hour professional dog training sessions within a 10-week period.
- Visit the clinical research unit four times during the study for data collection.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
Estudio Contacto
- Nombre: Beth A Pratt, PhD
- Número de teléfono: 561-297-4227
- Correo electrónico: bpratt4@health.fau.edu
Ubicaciones de estudio
-
-
Florida
-
Boca Raton, Florida, Estados Unidos, 33431
- Reclutamiento
- Florida Atlantic University
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Military veteran with self-reported posttraumatic stress symptoms and/or other mental health conditions
- Over 18 years of age
- Applied and approved to adopt a shelter dog for training through the Humane Society of Broward County in Fort Lauderdale, Florida
- English speaker (written and spoken)
- Home internet access via tablet, computer or smartphone.
Exclusion Criteria:
- Fear of dogs
- Allergies to pet dander
- Uncorrected hearing or visual impairment.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Otro
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Study Intervention
Within-subjects design |
Eight, one-hour professional dog training sessions over 8-10 weeks |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in self-reported posttraumatic stress disorder (PTSD) symptoms from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) is a 20-item self-report measure of PTSD symptoms with scores ranging from 0 to 80. |
From enrollment to 4 weeks post-intervention
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in depression symptom severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Patient Health Questionnaire-9 (PHQ-9) is a 9-item self-report measure of depressive symptoms with scores ranging from 0 to 27. |
From enrollment to 4 weeks post-intervention
|
|
Change in anxiety symptom severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Generalized Anxiety Disorder-7 (GAD-7) is a is a 7-item self-report measure of anxiety symptoms with scores ranging from 0 to 21. |
From enrollment to 4 weeks post-intervention
|
|
Change in perceived stress severity from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Perceived Stress Scale-10 (PSS-10) is a 10-item self-report measure of perceived stress symptoms with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in sleep disturbance from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Patient-Reported Outcomes Measurement Information System Sleep 8b (PROMIS Sleep 8b) is an 8-item self-report measure of sleep quality over the past 7 days with raw scores ranging from 8 to 40 and standardized T scores ranging from 28.9 to 76.5. |
From enrollment to 4 weeks post-intervention
|
|
Change in loneliness from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Revised UCLA Loneliness Scale is a 20-item self-report measure of loneliness with scores ranging from 20 to 80. |
From enrollment to 4 weeks post-intervention
|
|
Change in alcohol use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Alcohol Use Disorder Identification Test (AUDIT) is a 10-item self-report measure of alcohol use with scores ranging from 0 to 40. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Cannabis Use Disorder Identification Test (CUDIT) is an 8-item self-report measure of cannabis use with scores ranging from 0 to 32. |
From enrollment to 4 weeks post-intervention
|
|
Change in salivary oxytocin levels from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Oxytocin is a neurotransmitter that plays a role in determining social behavior. Salivary oxytocin levels range from 6.4-1000 pg/mL. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-1 beta (IL-1β) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
IL-1β is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-1β is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in Interleukin-6 (IL-6) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
IL-6 is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. IL-6 is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
|
Change in tumor necrosis factor-alpha (TNF-alpha) from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
TNF-alpha is a pro-inflammatory cytokine found to be higher in individuals with PTSD compared to healthy controls. TNF-alpha is measured via capillary blood obtained via fingerstick. |
From enrollment to 4 weeks post-intervention
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in alcohol demand for participants who answer "yes" to alcohol consumption in the AUDIT measure from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Alcohol Purchase Task is a tool to measure alcohol demand by asking individuals how many drinks they would consume at prices ranging from free to high, using behavioral economic indices for scoring. |
From enrollment to 4 weeks post-intervention
|
|
Change in cannabis demand for participants who answer "yes" to cannabis use from baseline to 4 weeks post-intervention
Periodo de tiempo: From enrollment to 4 weeks post-intervention
|
Cannabis Purchase Task is a tool to measure cannabis demand by assessing how much an individual purchases at increasing prices. |
From enrollment to 4 weeks post-intervention
|
|
Change in Magnetic Resonance Imaging (MRI) biomarkers from baseline to 4 weeks post-intervention
Periodo de tiempo: Pre-intervention and 4 weeks post-intervention
|
Optional participation in an MRI to detect changes in the structure and resting-state function of specific brain regions (anterior cingulate, amygdala, hippocampus, and insula) |
Pre-intervention and 4 weeks post-intervention
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Beth A Pratt, PhD, Florida Atlantic University
- Investigador principal: Cheryl A Krause-Parello, PhD, Florida Atlantic University
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
Otros números de identificación del estudio
- IRB2310227
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .